Oct, 1, 2023

Vol.30 No.2, pp. 84-88


Review

  • Korean Journal of Biological Psychiatry
  • Volume 4(2); 1997
  • Article

Review

Korean Journal of Biological Psychiatry 1997;4(2):162-7. Published online: Feb, 1, 1997

Role of Serotonin in Pathophysiology and Treatment of Schizophrenia

  • So-Young Park, MD; and Kyu-Hee Hahn, MD
    Department of Psychiatry, College of Medicine, Gyeongsang National University, Chinju, Korea
Abstract

There is no doubt that dopamine plays a critical role in the etiopathogenesis of schizophrenia. However, there appeared some limitations in explaining the complex phenomena of schizophrenia. Recent research data suggest that dysfunction in serotonergic system may be involved. Before the dopamine hypothesis of schizophrenia became established, the interest in serotonin(5-hydroxytryptamine, 5-HT) as an etiological substrate of this illness occurred. Recently the importance and extent of 5-HT’s involvement in the pathophysiology and mechanism of action of antipsychotic drug is actively investigated. In recent years, therapeutic success of clozapine and risperidones has increased attention on the interaction between the 5-HT and dopamine systems in schizophrenia. This led to the concept of serotonin-dopamine antagonist for antipsychotics. The authors review the evidence for the role of 5-HT in schizophrenia and serotonin-dopamine interaction.

Keywords Serotonin;Schizophrenia;Serotonin-dopamine antagonist.